Share the Video:

Assessing Syncretic Ayahuasca Practices Globally: Results from a multi-site cohort study of ayahuasca drinkers in non-tribal contexts

Saleena Subaiya

Ayahuasca is a psychoactive tea brewed from the Amazonian plants, Banisteriopsis caapi with either Psychotria viridis or Diplopterys cabrerana, with recent trials demonstrating promise in treating depression, managing grief, and improving overall well-being. In the last three decades, ritual ayahuasca use has expanded to most urban centers throughout the world, with hundreds of participants estimated to be taking ayahuasca every night in the United States for addressing anxiety and depression. More information is needed regarding the therapeutic impact of naturalistic ayahuasca use on behavioral health outcomes.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

The biological antidepressant effects of Ayahuasca

Ayahuasca shows promise as a treatment for major depression, with a trial indicating significant reduction in symptoms and improvements in physiological systems linked to depression. Research on psychedelics for depression

Nicole Galvão-Coelho

PS2023 Anxiety Depression Health Conditions Psilocybin Psychedelic Assisted Therapy Research and Science

Psilocybin Therapy in Advanced Cancer

Psilocybin trial for advanced cancer patients will compare effects of 25mg dose to 1mg placebo on anxiety, depression, and existential distress, using psychotherapy to assess efficacy and psychological mechanisms.

PS2023 Anxiety Depression Health Conditions LSD Psychedelic Assisted Therapy Research and Science

A randomized controlled trial of LSD-assisted psychotherapy to treat metastatic cancer induced bone pain

Metastatic breast cancer-induced bone pain (CIBP) is a common, severe pain type affecting many patients, lacking effective treatment options. A proposed study explores LSD therapy's potential efficacy for CIBP treatment.

Stephen Ross

PS2023 Ayahuasca Indigenous People Plant Medicine Psychedelic Assisted Therapy Research and Science Substance Use Disorder

Ayahuasca-assisted addiction treatment in Peru: results, challenges, and promises from a multi-year, mixed-methods study at Takiwasi Center

Ayahuasca's potential for treating mental disorders is explored through a study at Takiwasi Center, a Peruvian facility offering an ayahuasca-assisted addiction program. The study evaluates outcomes up to 24 months

Olivia Marcus

PS2023 Depression Indigenous People Ketamine Plant Medicine Psychedelic Assisted Therapy Research and Science

Considering psychedelic therapy for adolescents

Psychedelic-assisted therapies for adolescents are discussed, including the use of ketamine for treatment-resistant depression and the need for further studies and careful consideration of risks. Traditional use of plant medicines

Corine de Boer, Rebecca Kronman, Glauber Assis

PS2023 Anxiety Depression Mental Health Psilocybin Research and Science Spirituality

Naturalistic Psilocybin Use is Associated with Persisting Improvements in Mental Health and Well-being in a Large Prospective Sample

Results from the largest prospective survey of psilocybin use show that 30% of participants found the experience highly meaningful at 2-4 weeks, with positive effects on mental health persisting at

Sandeep Nayak, Nathan Sepeda, David Mathai

PS2023 Depression Psilocybin Psychedelic Assisted Therapy Psychedelic Science Research Research and Science

How do psychedelics work?

Robin Carhart-Harris, Head of Centre for Psychedelic Research at Imperial College London, conducted pioneering clinical studies with psilocybin and other psychedelic drugs for over 40 years. He collaborates with Professor

PS2023 Health Conditions Indigenous People Plant Medicine Psychedelic Assisted Therapy Research and Science Substance Use Disorder

Intercultural entheogenic medicine in the treatment of addictions and other mental health challenges

Entheogens are being used in traditional Indigenous medicine practices for therapeutic purposes. Indigenous initiatives are creating intercultural clinics to offer entheogen-assisted treatments for substance use disorders and mental health challenges.

Anja Loizaga-Velder

PS2023 Anxiety Depression Psychedelic Science Research Research and Science

Assessing the evidence for microdosing

Microdosing psychedelics: media attention for mood, creativity, anxiety relief. Explore data on benefits and myths in a critical analysis.

Harriet de Wit, Balázs Szigeti, Eline Haijen

Assessing Syncretic Ayahuasca Practices Globally: Results from a multi-site cohort study of ayahuasca drinkers in non-tribal contexts

Become a MAPS Member with a monthly donation

Related Videos